{"count": 14, "results": [{"_id": "34250095", "pmid": 34250095, "pmcid": "PMC8218917", "title": "Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning", "journal": "Biomed Res Int", "authors": ["Davoudi A", "Ahmadi M", "Sharifi A", "Hassantabar R", "Najafi N", "Tayebi A", "Kasgari HA", "Ahmadi F", "Rabiee M"], "date": "2021-06-19T00:00:00Z", "doi": "10.1155/2021/9995073", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "9995073", "score": 50273.703, "text_hl": "According to the results, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ reduced @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ severity significantly. ", "citations": {"NLM": "Davoudi A, Ahmadi M, Sharifi A, Hassantabar R, Najafi N, Tayebi A, Kasgari HA, Ahmadi F, Rabiee M. Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning Biomed Res Int. 2021;2021():9995073. PMID: 34250095", "BibTeX": "@article{34250095, title={Studying the Effect of Taking Statins before Infection in the Severity Reduction of COVID-19 with Machine Learning}, author={Davoudi A and Ahmadi M and Sharifi A and Hassantabar R and Najafi N and Tayebi A and Kasgari HA and Ahmadi F and Rabiee M}, journal={Biomed Res Int}, volume={2021}, pages={9995073}}"}}, {"_id": "32802982", "pmid": 32802982, "pmcid": "PMC7418767", "title": "Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz", "journal": "Heliyon", "authors": ["Jordaan MA", "Ebenezer O", "Damoyi N", "Shapi M"], "date": "2020-08-11T00:00:00Z", "doi": "10.1016/j.heliyon.2020.e04642", "meta_date_publication": "2020 Aug", "meta_volume": "6", "meta_issue": "8", "meta_pages": "e04642", "score": 50263.973, "text_hl": "The results of the study showed that @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ might be considered as lead compounds for further development for @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ main protease inhibitors.", "citations": {"NLM": "Jordaan MA, Ebenezer O, Damoyi N, Shapi M. Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz Heliyon. 2020 Aug;6(8):e04642. PMID: 32802982", "BibTeX": "@article{32802982, title={Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz}, author={Jordaan MA and Ebenezer O and Damoyi N and Shapi M}, journal={Heliyon}, volume={6}, number={8}, pages={e04642}}"}}, {"_id": "37888913", "pmid": 37888913, "pmcid": "PMC10755839", "title": "Simvastatin in Critically Ill Patients with Covid-19", "journal": "N Engl J Med", "authors": ["REMAP-CAP Investigators", "Hills TE", "Lorenzi E", "Berry LR", "Shyamsundar M", "Al-Beidh F", "Annane D", "Arabi Y", "Aryal D", "Au C", "Beane A", "Bhimani Z", "Bonten M", "Bradbury CA", "Brunkhorst FM", "Burrell A", "Buxton M", "Calfee CS", "Cecconi M", "Cheng AC", "Cove ME", "Detry MA", "Estcourt LJ", "Fitzgerald M", "Goligher EC", "Goossens H", "Green C", "Haniffa R", "Harrison DA", "Hashmi M", "Higgins AM", "Huang DT", "Ichihara N", "Jayakumar D", "Kruger PS", "Lamontagne F", "Lampro L", "Lawler PR", "Marshall JC", "Mason AJ", "McGlothlin A", "McGuinness S", "McQuilten ZK", "McVerry BJ", "Mouncey PR", "Murthy S", "Neal MD", "Nichol AD", "O'Kane CM", "Parke RL", "Parker JC", "Rabindrarajan E", "Reyes LF", "Rowan KM", "Saito H", "Santos M", "Saunders CT", "Seymour CW", "Shankar-Hari M", "Sinha P", "Thompson BT", "Turgeon AF", "Turner AM", "van de Veerdonk FV", "Weis S", "Young IS", "Zarychanski R", "Lewis RJ", "McArthur CJ", "Angus DC", "Berry SM", "Derde LPG", "Webb SA", "Gordon AC", "McAuley DF"], "date": "2023-10-25T00:00:00Z", "doi": "10.1056/NEJMoa2309995", "meta_date_publication": "2023 Oct 25", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50263.586, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in Critically Ill @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@Covid-19@@@", "citations": {"NLM": "REMAP-CAP Investigators, Hills TE, Lorenzi E, Berry LR, Shyamsundar M, Al-Beidh F, Annane D, Arabi Y, Aryal D, Au C, Beane A, Bhimani Z, Bonten M, Bradbury CA, Brunkhorst FM, Burrell A, Buxton M, Calfee CS, Cecconi M, Cheng AC, Cove ME, Detry MA, Estcourt LJ, Fitzgerald M, Goligher EC, Goossens H, Green C, Haniffa R, Harrison DA, Hashmi M, Higgins AM, Huang DT, Ichihara N, Jayakumar D, Kruger PS, Lamontagne F, Lampro L, Lawler PR, Marshall JC, Mason AJ, McGlothlin A, McGuinness S, McQuilten ZK, McVerry BJ, Mouncey PR, Murthy S, Neal MD, Nichol AD, O'Kane CM, Parke RL, Parker JC, Rabindrarajan E, Reyes LF, Rowan KM, Saito H, Santos M, Saunders CT, Seymour CW, Shankar-Hari M, Sinha P, Thompson BT, Turgeon AF, Turner AM, van de Veerdonk FV, Weis S, Young IS, Zarychanski R, Lewis RJ, McArthur CJ, Angus DC, Berry SM, Derde LPG, Webb SA, Gordon AC, McAuley DF. Simvastatin in Critically Ill Patients with Covid-19 N Engl J Med. 2023 Oct 25;():. PMID: 37888913", "BibTeX": "@article{37888913, title={Simvastatin in Critically Ill Patients with Covid-19}, author={REMAP-CAP Investigators and Hills TE and Lorenzi E and Berry LR and Shyamsundar M and Al-Beidh F and Annane D and Arabi Y and Aryal D and Au C and Beane A and Bhimani Z and Bonten M and Bradbury CA and Brunkhorst FM and Burrell A and Buxton M and Calfee CS and Cecconi M and Cheng AC and Cove ME and Detry MA and Estcourt LJ and Fitzgerald M and Goligher EC and Goossens H and Green C and Haniffa R and Harrison DA and Hashmi M and Higgins AM and Huang DT and Ichihara N and Jayakumar D and Kruger PS and Lamontagne F and Lampro L and Lawler PR and Marshall JC and Mason AJ and McGlothlin A and McGuinness S and McQuilten ZK and McVerry BJ and Mouncey PR and Murthy S and Neal MD and Nichol AD and O'Kane CM and Parke RL and Parker JC and Rabindrarajan E and Reyes LF and Rowan KM and Saito H and Santos M and Saunders CT and Seymour CW and Shankar-Hari M and Sinha P and Thompson BT and Turgeon AF and Turner AM and van de Veerdonk FV and Weis S and Young IS and Zarychanski R and Lewis RJ and McArthur CJ and Angus DC and Berry SM and Derde LPG and Webb SA and Gordon AC and McAuley DF}, journal={N Engl J Med}}"}}, {"_id": "33594363", "pmid": 33594363, "pmcid": "PMC7885915", "title": "Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin", "journal": "bioRxiv", "authors": ["Qian Y", "Lei T", "Patel PS", "Lee CH", "Monaghan-Nichols P", "Xin HB", "Qiu J", "Fu M"], "date": "2021-02-18T00:00:00Z", "doi": "10.1101/2021.02.14.431174", "meta_date_publication": "2021 Feb 18", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50254.57, "text_hl": "Our results justify that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ may be more benefit for the treatment of @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ by potently suppressing endothelial activation.", "citations": {"NLM": "Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, Qiu J, Fu M. Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin bioRxiv. 2021 Feb 18;():. PMID: 33594363", "BibTeX": "@article{33594363, title={Direct activation of endothelial cells by SARS-CoV-2 nucleocapsid protein is blocked by Simvastatin}, author={Qian Y and Lei T and Patel PS and Lee CH and Monaghan-Nichols P and Xin HB and Qiu J and Fu M}, journal={bioRxiv}}"}}, {"_id": "34549987", "pmid": 34549987, "pmcid": "PMC8577385", "title": "Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin", "journal": "J Virol", "authors": ["Qian Y", "Lei T", "Patel PS", "Lee CH", "Monaghan-Nichols P", "Xin HB", "Qiu J", "Fu M"], "date": "2021-11-09T00:00:00Z", "doi": "10.1128/JVI.01396-21", "meta_date_publication": "2021 Nov 9", "meta_volume": "95", "meta_issue": "23", "meta_pages": "e0139621", "score": 50253.215, "text_hl": "Our results indicate that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ may be of more benefit for the treatment of @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ by potently suppressing endothelial activation.", "citations": {"NLM": "Qian Y, Lei T, Patel PS, Lee CH, Monaghan-Nichols P, Xin HB, Qiu J, Fu M. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin J Virol. 2021 Nov 9;95(23):e0139621. PMID: 34549987", "BibTeX": "@article{34549987, title={Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin}, author={Qian Y and Lei T and Patel PS and Lee CH and Monaghan-Nichols P and Xin HB and Qiu J and Fu M}, journal={J Virol}, volume={95}, number={23}, pages={e0139621}}"}}, {"_id": "35251001", "pmid": 35251001, "pmcid": "PMC8895251", "title": "Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts", "journal": "Front Immunol", "authors": ["Teixeira L", "Temerozo JR", "Pereira-Dutra FS", "Ferreira AC", "Mattos M", "Gonçalves BS", "Sacramento CQ", "Palhinha L", "Cunha-Fernandes T", "Dias SSG", "Soares VC", "Barreto EA", "Cesar-Silva D", "Fintelman-Rodrigues N", "Pão CRR", "de Freitas CS", "Reis PA", "Hottz ED", "Bozza FA", "Bou-Habib DC", "Saraiva EM", "de Almeida CJG", "Viola JPB", "Souza TML", "Bozza PT"], "date": "2022-02-18T00:00:00Z", "doi": "10.3389/fimmu.2022.820131", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "820131", "score": 50249.945, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Downregulates Inflammatory Response Triggered by @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@SARS-CoV-2 Infection@@@ in @SPECIES_9606 @@@Human@@@ Monocytes", "citations": {"NLM": "Teixeira L, Temerozo JR, Pereira-Dutra FS, Ferreira AC, Mattos M, Gonçalves BS, Sacramento CQ, Palhinha L, Cunha-Fernandes T, Dias SSG, Soares VC, Barreto EA, Cesar-Silva D, Fintelman-Rodrigues N, Pão CRR, de Freitas CS, Reis PA, Hottz ED, Bozza FA, Bou-Habib DC, Saraiva EM, de Almeida CJG, Viola JPB, Souza TML, Bozza PT. Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts Front Immunol. 2022;13():820131. PMID: 35251001", "BibTeX": "@article{35251001, title={Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid Rafts}, author={Teixeira L and Temerozo JR and Pereira-Dutra FS and Ferreira AC and Mattos M and Gonçalves BS and Sacramento CQ and Palhinha L and Cunha-Fernandes T and Dias SSG and Soares VC and Barreto EA and Cesar-Silva D and Fintelman-Rodrigues N and Pão CRR and de Freitas CS and Reis PA and Hottz ED and Bozza FA and Bou-Habib DC and Saraiva EM and de Almeida CJG and Viola JPB and Souza TML and Bozza PT}, journal={Front Immunol}, volume={13}, pages={820131}}"}}, {"_id": "36426391", "pmid": 36426391, "title": "Simvastatin Therapy Increased miR-150-5p : Expression in the Patients with Type 2 Diabetes and COVID-19.", "journal": "Cell Physiol Biochem", "authors": ["AmeliMojarad M", "AmeliMojarad M", "Pourmadian A"], "date": "2022-11-25T00:00:00Z", "doi": "10.33594/000000590", "meta_date_publication": "2022 Nov 25", "meta_volume": "56", "meta_issue": "6", "meta_pages": "685-691", "score": 50249.285, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Therapy Increased miR-150-5p : Expression in the @SPECIES_9606 @@@Patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@ and @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@.", "citations": {"NLM": "AmeliMojarad M, AmeliMojarad M, Pourmadian A. Simvastatin Therapy Increased miR-150-5p : Expression in the Patients with Type 2 Diabetes and COVID-19. Cell Physiol Biochem. 2022 Nov 25;56(6):685-691. PMID: 36426391", "BibTeX": "@article{36426391, title={Simvastatin Therapy Increased miR-150-5p : Expression in the Patients with Type 2 Diabetes and COVID-19.}, author={AmeliMojarad M and AmeliMojarad M and Pourmadian A}, journal={Cell Physiol Biochem}, volume={56}, number={6}, pages={685-691}}"}}, {"_id": "35441166", "pmid": 35441166, "title": "Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.", "journal": "medRxiv", "authors": ["Sperry MM", "Oskotsky T", "MariÄ I", "Kaushal S", "Takeda T", "Horvath V", "Powers RK", "Rodas M", "Furlong B", "Soong M", "Prabhala P", "Goyal G", "Carlson KE", "Wong RJ", "Kosti I", "Le BL", "Logue J", "Hammond H", "Frieman M", "Stevenson DK", "Ingber DE", "Sirota M", "Novak R"], "date": "2022-07-22T00:00:00Z", "doi": "10.1101/2022.04.12.22273802", "meta_date_publication": "2022 Jul 22", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50244.63, "text_hl": "In vitro testing of @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@SARS-CoV-2 infected@@@ cells revealed @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to be a potent direct inhibitor whereas most other statins were less effective. ", "citations": {"NLM": "Sperry MM, Oskotsky T, MariÄ I, Kaushal S, Takeda T, Horvath V, Powers RK, Rodas M, Furlong B, Soong M, Prabhala P, Goyal G, Carlson KE, Wong RJ, Kosti I, Le BL, Logue J, Hammond H, Frieman M, Stevenson DK, Ingber DE, Sirota M, Novak R. Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients. medRxiv. 2022 Jul 22;():. PMID: 35441166", "BibTeX": "@article{35441166, title={Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients.}, author={Sperry MM and Oskotsky T and MariÄ I and Kaushal S and Takeda T and Horvath V and Powers RK and Rodas M and Furlong B and Soong M and Prabhala P and Goyal G and Carlson KE and Wong RJ and Kosti I and Le BL and Logue J and Hammond H and Frieman M and Stevenson DK and Ingber DE and Sirota M and Novak R}, journal={medRxiv}}"}}, {"_id": "37146076", "pmid": 37146076, "pmcid": "PMC10191356", "title": "Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients", "journal": "PLoS Comput Biol", "authors": ["Sperry MM", "Oskotsky TT", "Marić I", "Kaushal S", "Takeda T", "Horvath V", "Powers RK", "Rodas M", "Furlong B", "Soong M", "Prabhala P", "Goyal G", "Carlson KE", "Wong RJ", "Kosti I", "Le BL", "Logue J", "Hammond H", "Frieman M", "Stevenson DK", "Ingber DE", "Sirota M", "Novak R"], "date": "2023-05-05T00:00:00Z", "doi": "10.1371/journal.pcbi.1011050", "meta_date_publication": "2023 May", "meta_volume": "19", "meta_issue": "5", "meta_pages": "e1011050", "score": 50244.258, "text_hl": "In vitro testing of @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@SARS-CoV-2 infected@@@ cells revealed @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to be a potent direct inhibitor whereas most other statins were less effective. ", "citations": {"NLM": "Sperry MM, Oskotsky TT, Marić I, Kaushal S, Takeda T, Horvath V, Powers RK, Rodas M, Furlong B, Soong M, Prabhala P, Goyal G, Carlson KE, Wong RJ, Kosti I, Le BL, Logue J, Hammond H, Frieman M, Stevenson DK, Ingber DE, Sirota M, Novak R. Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients PLoS Comput Biol. 2023 May;19(5):e1011050. PMID: 37146076", "BibTeX": "@article{37146076, title={Target-agnostic drug prediction integrated with medical record analysis uncovers differential associations of statins with increased survival in COVID-19 patients}, author={Sperry MM and Oskotsky TT and Marić I and Kaushal S and Takeda T and Horvath V and Powers RK and Rodas M and Furlong B and Soong M and Prabhala P and Goyal G and Carlson KE and Wong RJ and Kosti I and Le BL and Logue J and Hammond H and Frieman M and Stevenson DK and Ingber DE and Sirota M and Novak R}, journal={PLoS Comput Biol}, volume={19}, number={5}, pages={e1011050}}"}}, {"_id": "37486310", "pmid": 37486310, "title": "Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.", "journal": "J Med Virol", "authors": ["Visos-Varela I", "Zapata-Cachafeiro M", "Pintos-Rodríguez S", "Bugarín-González R", "González-Barcala FJ", "Herdeiro MT", "Piñeiro-Lamas M", "Figueiras A", "Salgado-Barreira Á"], "date": "2023-07-01T00:00:00Z", "doi": "10.1002/jmv.28971", "meta_date_publication": "2023 Jul", "meta_volume": "95", "meta_issue": "7", "meta_pages": "e28971", "score": 50243.605, "text_hl": "The results of this real-world study suggest that chronic use of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ (and to a lesser degree, of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@) is associated with a decrease in risk of severe @<m>DISEASE_COVID_19</m> @DISEASE_MESH:D000086382 @@@COVID-19@@@ outcomes.", "citations": {"NLM": "Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodríguez S, Bugarín-González R, González-Barcala FJ, Herdeiro MT, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study. J Med Virol. 2023 Jul;95(7):e28971. PMID: 37486310", "BibTeX": "@article{37486310, title={Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.}, author={Visos-Varela I and Zapata-Cachafeiro M and Pintos-Rodríguez S and Bugarín-González R and González-Barcala FJ and Herdeiro MT and Piñeiro-Lamas M and Figueiras A and Salgado-Barreira Á}, journal={J Med Virol}, volume={95}, number={7}, pages={e28971}}"}}]}